Showing results (1661-1670 of 2,131) with videos related to
Sort By:
Pageof 214
JAMA Oncology|December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical TrialIrene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.Journal of the National Cancer Institute|July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)Yara Abdou, Jess Hoag, William E Barlow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004Eric P Winer, Clifford Hudis, Harold J Burstein, et al.Circulation|December 28, 2018
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 StudyPaolo C Colombo, Mandeep R Mehra, Daniel J Goldstein, et al.Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.Scientific Reports|July 19, 2022
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planningSema Nickbakhsh, Joseph Hughes, Nicolaos Christofidis, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.JACC. Heart Failure|October 10, 2015
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation StrategiesJeffrey J Teuteberg, Mark S Slaughter, Joseph G Rogers, et al.Biorxiv : the Preprint Server for Biology|October 17, 2024
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.Pageof 214